Skip to main navigation Join Our Team Contact Us COMPANY EXHALATION DELIVERY SYSTEMS THERAPEUTIC AREAS PRODUCTS RESEARCH & DEVELOPMENT INVESTORS NEWS & MEDIA SCIENTIFIC COMMUNICATIONS FAQ Where is Optinose’s Corporate headquarters? Where is Optinose incorporated? When is Optinose’s fiscal year-end? Who is Optinose’s independent registered public accounting firm? Who is Optinose’s corporate counsel? On which exchange is Optinose listed and what is the ticker symbol? When did Optinose go public? How can I purchase shares of Optinose? Does Optinose have a direct stock purchase plan? Who is Optinose’s transfer agent and how do I contact them? How can I replace my lost stock certificates? How do I report a change of mailing address? Where can I view documents that Optinose has filed with the Securities & Exchange Commission (SEC)? Where can I find recent Optinose press releases? Who can I contact if I am a member of the media? How do I contact Investor Relations with a question or request? Investors News & Events Stock Information Corporate Governance SEC Filings Proxy Materials Investor Resources FAQ Investor Contact Email Alerts Toolkit Print page Sign up for email alerts Investor Contact Jonathan Neely VP Investor Relations and Business Operations Email: investors@optinose.com Contact Us P.O. Terms & Conditions Join Our Team Privacy Policy Terms of Use Site Map ©2021 Optinose. OPTINOSE-17-013a 09/2017